Last reviewed · How we verify

NCT07525154

Development of a Certified Testing Procedure for Hip and Groin Injuries in Athletes

Not yet recruiting NA Last updated 13 April 2026
What this trial tests

NA trial testing Strength-focused in Hip Injury in 170 participants. Not yet recruiting.

Timeline
1 January 2027
Primary endpoint
31 December 2031
31 December 2031

Quick facts

Lead sponsorCharles University, Czech Republic
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingnone
Primary purposescreening
Enrollment170
Start date1 January 2027
Primary completion31 December 2031
Estimated completion31 December 2031

Drugs / interventions tested

Conditions studied

Sponsor

Charles University, Czech Republic

Who can join

Adults 14 to 20, any sex, with Hip Injury. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Hip and groin injuries affect approximately 21% of professional athletes annually, causing significant time loss. As roughly 48% of these cases result from non-contact mechanisms, they are potentially preventable through optimized diagnostic screening. Evidence strongly links restricted hip range of motion (ROM) and strength deficits to an increased injury risk. This project aims to (1) develop a rigorously validated diagnostic testing procedure by comparing different joint positions, movement velocities, and muscle contractions to establish a preventive "gold standard" screening battery. dditionally, (2) pilot targeted prevention interventions over a competitive season. Using a crossover design, the research evaluates three protocols: Strength-focused,Flexibility-focused:and control group. (3) Implement of a Centralized Injury Reporting System. Combining comprehensive diagnostic screening with these practical interventions will yield a powerful tool for clinicians and coaches to effectively reduce the incidence and burden of non-contact hip and groin injuries

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Charles University, Czech Republic trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07525154.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing